Patnaik, A., Sharma, M. R., McKean, W. B., Joshi, R., Giordano, A., Tang, S., Sun, L., Shaw, M., Lau, J., Patel, M. R. (2026). A phase 1, first-in-human study of OP-3136, a novel oral selective KAT6A/B inhibitor, as monotherapy in advanced solid tumors and in combination with endocrine therapy in ER+, HER2− advanced breast cancer (ABC): Preliminary results.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.3088